CHMP Recommends Lilly and Boehringer Ingelheim ’s New Insulin Glargine Product for Approval in the European Union

CHMP Recommends Lilly and Boehringer Ingelheim ’s New Insulin Glargine Product for Approval in the European Union
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Insulin | Lantus | Research